Deregulation of the TNF-α signaling pathway is associated with many inflammatory disorders, including rheumatoid arthritis, and inflammatory bowel disease, as the monoclonal antibody to TNF-α has been a standard treatment for these diseases. Here, TNF is linked to inflammatory bowel disease.